Cargando…
Measuring severe adverse events and medication selection using a “PEER Report” for nonpsychotic patients: a retrospective chart review
We previously reported on an objective new tool that uses quantitative electroencephalography (QEEG) normative- and referenced-electroencephalography sampling databases (currently called Psychiatric EEG Evaluation Registry [PEER]), which may assist physicians in determining medication selection for...
Autores principales: | Hoffman, Daniel A, DeBattista, Charles, Valuck, Robert J, Iosifescu, Dan V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395405/ https://www.ncbi.nlm.nih.gov/pubmed/22802691 http://dx.doi.org/10.2147/NDT.S31665 |
Ejemplares similares
-
The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy
por: Iosifescu, Dan V, et al.
Publicado: (2016) -
Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders
por: Greenblatt, James M, et al.
Publicado: (2011) -
Nonpsychotic Hallucinations and Impaired Vision: The Charles Bonnet Syndrome
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021) -
The impact of nonpsychotic postpartum psychiatric disorders (NPPDs) on offspring
por: Stojanov, J., et al.
Publicado: (2023) -
Symptom Profile and Severity in a Sample of Nigerians with Psychotic versus Nonpsychotic Major Depression
por: Adeosun, Increase Ibukun, et al.
Publicado: (2013)